The nation of Zimbabwe has declined a major US health deal valued at $367m (272 million pounds) over five years because of the United States' insistence on sensitive biological samples.
This move was revealed following a government memo from December was disclosed, indicating that President Emmerson Mnangagwa deemed the arrangement was "skewed".
A government spokesperson has since stated that the United States was demanding access to health data for scientific study and commercial gain but was unwilling to share the resulting advantages from any future treatments.
"We must now begin the challenging and unfortunate process of scaling back our health assistance in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy said the United States had provided more than $1.9bn for health programmes to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has appealed for continued talks to secure a deal agreeable to all parties so the country's critical HIV programme can proceed.
Wider Background
This development comes after a similar case in neighbouring Kenya, where a court suspended a related health funding agreement after legal challenges were filed about the safety of citizens' health data.
Since resuming the presidency recently, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).
The agency had overseen assistance for the US government, but Trump claimed its spending was "wasteful" and his administration was pursuing direct bilateral deals to enhance openness and accountability.
According to statements, Sixteen African countries have to date agreed to similar agreements, constituting more than $18.3bn of fresh investment.
Specifics of the Declined Deal
The money for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and preparing for epidemics".
"We believe this cooperation might have yielded significant benefits for Zimbabwean communities, particularly the 1.2 million presently on HIV treatment via US-supported programmes," Tremont added.
However, government spokesperson Nick Mangwana said the proposed deal was "asymmetrical".
"The proposal required Zimbabwe to share its genetic material and health information over an extended period, without any corresponding guarantee of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could be developed from that shared data," he stated.
"Effectively, our nation would supply the basic resources for scientific discovery with no certainty that the resulting innovations would be available to our citizens if a new health crisis arise."
Sovereignty and Global Health
He also said that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral health agreements were disrupting structures previously established through the international health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing framework created to deal with future global health emergencies.
"This mechanism is designed to ensure that when a nation provides its data, the benefits – including vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the funds to develop them."
The government's concerns regarding the US deal "are not meant as opposition to America," he added.
"We welcome ongoing dialogue with our American counterparts on how subsequent collaboration could be arranged in a manner that respects the sovereignty and dignity of both nations."
Health Experts Response
A leading public health body expressed it recognised the official position, but suggested that talks must proceed since a large portion of the nation's HIV programmes depended on foreign aid.
"If technical issues exist, including those involving data governance or agreement terms, these can frequently be addressed through technical clarification and mutually agreed protections," the group commented.
The halted deal underscores the continuing tensions between receiving vital international aid and protecting local interests in an increasingly interconnected world.